Clinical Trial

Hematological Disorders in Patients With GI Angiodysplasia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study will be to assess the association between GIT angiodysplasia with any hematological disorders as von Willebrand factor and Prognostic value of von Willebrand factor on patient's outcomes as risk of rebleeding and hospital mortality
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-14.
Trial Details
NCT Number NCT07183995
Lead Sponsor Assiut University
Conditions GI Bleeding
Enrollment 55 participants
Start Date 2025-09
Primary Completion 2026-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2025-09-25